Overview Request Sample Pages Request Customization Download PDF
You are viewing: Europe Companion Animal Diagnostic Market analysis

The Europe Companion Animal Diagnostic Market was valued at $907.7 Million in 2026 and projected to reach to $1337.7 Million by 2031, representing a compound annual growth rate of 8.1%. Europe's companion animal diagnostic market is positioned for sustained growth through 2031, driven by rising pet ownership, elevated consumer spending on pet healthcare, and widespread adoption of advanced diagnostic technologies.

Europe Companion Animal Diagnostic Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Companion Animal Diagnostic Market Trends and Insights

  • This expansion reflects Europe's strong pet ownership rates, advanced veterinary infrastructure, and increasing consumer spending on pet healthcare.
  • Europe leads in adoption of diagnostic technologies such as point-of-care testing, imaging systems, and laboratory diagnostics, driven by regulatory standards and pet owner awareness of preventive care. The European market benefits from a mature veterinary sector with established diagnostic service providers and a growing emphasis on early disease detection in companion animals.
  • Between 2026 and 2031, Europe is expected to maintain steady growth momentum as pet humanization trends intensify and veterinary clinics invest in advanced diagnostic capabilities.
  • Europe's regulatory environment and high disposable incomes support premium diagnostic offerings, positioning the region as a key growth market within the global companion animal diagnostic landscape..

Key Market Statistics

  • CAGR (2026-2031) 8.1% CAGR
  • Market Size, 2026 ~USD 907.7 Million
  • Forecast, 2031 ~USD 1337.7 Million
  • Geography Europe

Europe Companion Animal Diagnostic Market Overview

Market Valuation & Growth :

Europe's companion animal diagnostic market is valued at $907.7 million in 2026 and is projected to reach $1,337.7 million by 2031, representing a robust 8.1% CAGR over the forecast period.

Advanced Veterinary Infrastructure :

Europe benefits from well-established veterinary networks and high-quality diagnostic facilities, with strong adoption of point-of-care testing and advanced imaging technologies across the region.

Pet Ownership & Consumer Spending :

Europe demonstrates exceptionally high pet ownership rates coupled with increasing consumer willingness to invest in preventive and diagnostic pet healthcare, driving sustained market expansion.

Technology Leadership :

European markets lead in the adoption of innovative diagnostic solutions including point-of-care testing, digital imaging, and laboratory automation, setting regional standards for companion animal diagnostics.

Europe Companion Animal Diagnostic Market Dynamics

  • The region's mature veterinary infrastructure and regulatory frameworks support continuous innovation and market expansion.
  • Key growth drivers include increasing awareness of preventive care, aging pet populations requiring more frequent diagnostics, and the integration of digital health solutions in veterinary practices.
  • European pet owners' strong commitment to animal welfare and willingness to invest in quality healthcare ensure robust demand for diagnostic services and products..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Europe's companion animal diagnostic market will grow from $907.7M (2026) to $1,337.7M (2031) at an 8.1% CAGR.
    • Europe leads in diagnostic technology adoption, including point-of-care testing and advanced imaging systems for pets.
    • Pet humanization and preventive care awareness are primary growth drivers across Europe's veterinary sector.
    • Europe's mature veterinary infrastructure and high disposable incomes support premium diagnostic service expansion through 2031.

    Companion Animal Diagnostic Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment MOLECULAR DIAGNOSTICS (Technology)
    Forecast Period 2026–2031
    Growth Rate CAGR of 8.7% from 2026 to 2031
    Largest Segment CONSUMABLES (Product)
    Market Size Base Year (Billions) ~USD 3.56 (2026)
    Revenue Forecast (Billions) ~USD 5.4 (2031)
    Segments Covered Product, Technology, Type, Application, Animal Type, End User

    Europe Companion Animal Diagnostic Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Instruments

    By Technology

    • Clinical Biochemistry
    • Hematology
    • Immunodiagnostics
    • Molecular Diagnostics
    • Other Technologies
    • Urinalysis

    By Type

    • Allergen-Specific Immunodiagnostic Tests
    • Blood Gas & Electrolyte Analysis
    • Blood Gas & Electrolyte Analyzers
    • Blood Gas & Electrolyte Reagents, Clips, And Cartridges
    • Blood Glucose Strips
    • Clinical Chemistry Analysis
    • Clinical Chemistry Analyzers
    • Clinical Chemistry Reagents, Clips, And Cartridges
    • Elisa Tests
    • Glucose Monitoring
    • Glucose Monitors
    • Hematology Analyzers
    • Hematology Cartridges
    • Immunoassay Analyzers
    • Lateral Flow Assays
    • Microarrays
    • Nucleic Acid Sequencing
    • Other Immunodiagnostics Products
    • Other Molecular Diagnostics Products
    • Pcr Tests
    • Radioimmunoassays
    • Rapid Tests
    • Strip Readers
    • Urinalysis Clips & Cartridges
    • Urine Analyzers
    • Urine Glucose Strips
    • Urine Test Strips

    By Application

    • Bacteriology
    • Clinical Pathology
    • Other Applications
    • Parasitology
    • Virology

    By Animal Type

    • Cats
    • Dogs
    • Horses
    • Other Companion Animals

    By End User

    • Home Care Settings
    • Veterinary Hospital & Clinics
    • Veterinary Reference Laboratories
    • Veterinary Research Institutes & Universities

    EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    HOME CARE SETTINGS38.54246.451.45763.270.278.110.9
    VETERINARY HOSPITAL & CLINICS492.7522559.9601.2646.5696749.9809.57.7
    VETERINARY REFERENCE LABORATORIES207221.7240.3260.8283.5308.4335.8366.48.8
    VETERINARY RESEARCH INSTITUTES & UNIVERSITIES54.957.56164.96973.578.383.76.5
    TOTAL793843.3907.7978.21055.91141.11234.21337.78.1

    REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    HOME CARE SETTINGS5.766.256.857.538.289.1110.0311.0710.1
    VETERINARY HOSPITAL & CLINICS56.5159.316366.9871.3276.0181.0786.626.6
    VETERINARY REFERENCE LABORATORIES23.6625.1226.9929.0331.2733.7236.3839.327.8
    VETERINARY RESEARCH INSTITUTES & UNIVERSITIES6.276.526.867.227.618.038.498.985.5
    TOTAL92.2197.2103.71110.76118.48126.87135.971467.1

    Target Audience

    • Veterinary Diagnostic Companies : Manufacturers and suppliers of diagnostic equipment, reagents, and services need Europe-specific market data to develop products, set pricing strategies, and plan market entry or expansion across European territories.
    • Veterinary Practice Operators : Clinic owners and veterinary hospital chains require market insights to benchmark performance, identify technology investment opportunities, and understand competitive positioning within their regional markets.
    • Investment & Private Equity Firms : Investors evaluating acquisition targets, funding opportunities, or portfolio companies in the European veterinary diagnostics space need comprehensive market data to assess growth potential and valuation metrics.
    • Healthcare & Pharmaceutical Companies : Organizations expanding into companion animal healthcare or considering acquisitions in the European veterinary diagnostics market require detailed market analysis to inform strategic decisions.
    • Market Research & Consulting Professionals : Analysts, consultants, and research teams supporting clients in the veterinary and pet healthcare sectors need Europe-focused market data to develop strategies, reports, and recommendations.

    Key Companies in the Europe Companion Animal Diagnostic Market

    CompanyHQOwnershipStrongest segments
    MINDRAY MEDICAL INTERNATIONAL LIMITEDChinaPrivate CompanyPatient Monitoring and Life Support Products,In-Vitro Diagnostic Products,Medical Imaging Systems,
    QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response and infectious disease diagnostics (incl. TB IGRA, transplant, viral load),Oncology, sexual and reproductive health assays,
    IDEXX LABORATORIES, INC.United StatesPublic CompanyCompanion Animal Group – in-clinic analyzers and SNAP rapid assays,Companion Animal Group – reference laboratories and telemedicine/consulting,Veterinary software, services, VetConnect PLUS and VetLab Station,
    FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical devices, CDMO, pharma, regenerative medicine, cosmetics/supplements),Business Innovation (office equipment, document solutions, graphic communications, inkjet),Electronics (display, semiconductor materials, storage, industrial equipment, fine chemicals),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    BIOMéRIEUXFrancePublic CompanyClinical microbiology (culture media, VITEK 2, VITEK MS, AST including ETEST/VITEK REVEAL),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassays and CLIA (VIDAS, Hybiome),
    BIONOTESouth KoreaPublic CompanyVeterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits,
    VIRBACFrancePublic CompanyCompanion-animal parasiticides and anti-infectives,Companion-animal specialty therapeutics & behavior (CKD diets, pheromones, mobility),Farm-animal vaccines (swine focus: Suigen range),

    MINDRAY MEDICAL INTERNATIONAL LIMITED

    Mindray Medical International Limited is a Chinese medical device manufacturer founded in 1991 with 8,400 employees. Operating as a private company, it specializes in diagnostic and monitoring equipment for healthcare applications.

    QIAGEN NV

    QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. It provides molecular diagnostics, sample preparation, and life sciences research tools globally.

    IDEXX LABORATORIES, INC.

    IDEXX Laboratories, Inc. is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostic equipment and software for veterinary and water testing markets.

    FUJIFILM CORPORATION

    Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. It operates across imaging, diagnostics, pharmaceuticals, and industrial products globally.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States public company founded in 1956 with 125,000 employees. It is a leading provider of laboratory equipment, reagents, and analytical instruments worldwide.

    BIOMéRIEUX

    bioMérieux is a French public company founded in 1963 with 14,894 employees. It specializes in in vitro diagnostics and microbiology testing solutions for clinical and industrial applications.

    BIONOTE

    BioNote is a South Korean public company founded in 2003 with 298 employees. The company develops and manufactures diagnostic devices and reagents for veterinary and clinical use.

    VIRBAC

    Virbac is a French public company founded in 1968 with 6,442 employees. It specializes in veterinary pharmaceuticals and animal health products.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 2556.2 Million · 8.4% wtd CAGR ·
    Asia Pacific
    ~USD 1247.5 Million · 10.1% wtd CAGR ·
    Latin America
    ~USD 172.2 Million · 7.5% wtd CAGR ·
    Middle East & Africa
    ~USD 84.3 Million · 6.1% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 218.2 Million
    UKUSD 167.3 Million
    FranceUSD 147.5 Million
    ItalyUSD 103.2 Million
    SpainUSD 69.5 Million
    NetherlandsUSD 56.4 Million
    SwedenUSD 23.5 Million
    PolandUSD 18.7 Million
    Rest Of EuropeUSD 99.4 Million

    Country market size visualization

    Germany
    USD 218.2 Million
    UK
    USD 167.3 Million
    France
    USD 147.5 Million
    Italy
    USD 103.2 Million
    Spain
    USD 69.5 Million
    Netherlands
    USD 56.4 Million
    Sweden
    USD 23.5 Million
    Poland
    USD 18.7 Million
    Rest Of Europe
    USD 99.4 Million

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuations for Europe's companion animal diagnostic sector with country-level breakdowns, enabling accurate business planning and investment decisions specific to European markets.
    • Competitive Landscape Intelligence : Understand the competitive dynamics, market leaders, and emerging players within Europe's diagnostic market to identify partnership opportunities and competitive positioning strategies.
    • Technology Adoption Trends : Gain insights into European adoption rates of point-of-care testing, imaging, and laboratory automation technologies to align product development and market entry strategies with regional preferences.
    • Country-Specific Market Analysis : Access detailed market data for major European markets including Germany, UK, France, Italy, and Spain to tailor go-to-market strategies and resource allocation by country.
    • Growth Opportunity Identification : Identify high-growth segments, underserved markets, and emerging opportunities within Europe's companion animal diagnostic sector to prioritize expansion and investment initiatives.

    Frequently asked questions

    What is the current size of Europe's companion animal diagnostic market?

    Europe's companion animal diagnostic market is valued at $907.7 million in 2026 and is projected to reach $1,337.7 million by 2031.

    What is the expected growth rate for Europe's companion animal diagnostic market?

    Europe's companion animal diagnostic market is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2031.

    What diagnostic technologies are most prevalent in Europe?

    Europe leads in adoption of point-of-care testing, advanced imaging systems, laboratory diagnostics, and molecular diagnostic technologies for companion animals.

    What factors are driving growth in Europe's companion animal diagnostic market?

    Key drivers include pet humanization trends, increased consumer spending on pet healthcare, preventive care awareness, regulatory standards, and veterinary clinic investments in advanced diagnostics.

    How does Europe's market compare to global trends?

    Europe's 8.1% CAGR is slightly below the global 8.7% CAGR, but Europe maintains a mature, well-established diagnostic infrastructure with higher adoption of premium technologies.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the companion animal diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the companion animal diagnostics market. Primary sources from the demand side include R&D product development teams in animal health companies, veterinary clinicians, diagnostic laboratory managers, and procurement heads at veterinary reference laboratories.

    Companion Animal Diagnostic Market Size, and Share

    Note: C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
    Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the companion animal diagnostics market was determined through data triangulation across three approaches, as described below. After each approach, the weighted average of the three was calculated based on the level of assumptions used in each.

    Companion Animal Diagnostic Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed as applicable to complete the overall market engineering process and obtain exact statistics for all segments and subsegments.

    Market Definition

    Companion animal diagnostics use plasma, serum, blood, urine, feces, and tissue samples to detect, monitor, and manage diseases and health conditions in dogs, cats, horses, and other household pets. The companion animal diagnostics market includes diagnostic instruments, test kits, reagents, and consumables used in veterinary clinics and laboratories, covering technologies such as clinical chemistry analyzers, hematology analyzers, immunodiagnostics and ELISA test kits, urinalysis systems, molecular diagnostic assays, glucose monitoring systems, and blood gas–electrolyte analyzers. These products support routine wellness screening, disease diagnosis, treatment monitoring, and preventive healthcare in companion animals.

    Key Stakeholders

    • Companion animal diagnostic manufacturers
    • Companion animal diagnostic distributors and suppliers
    • Companion animal R&D companies
    • Veterinary reference laboratories
    • Veterinary hospitals and clinics
    • Veterinary universities and research institutes
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors
    • Distributors, channel partners, and third-party suppliers

    Report Objectives

    • To define, describe, segment, and forecast the companion animal diagnostics market by product, technology, application, animal type, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall companion animal diagnostics market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the companion animal diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the companion animal diagnostics market and comprehensively analyze their core competencies and market shares
    • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Available customizations:

    Based on the given market data, MarketsandMarkets offers customization to meet your company’s specific needs. The following customization options are available for the report:

    Company Information
    • Detailed analysis and profiling of additional market players (up to 5)
    Geographic Analysis
    • Further breakdown of the Rest of European companion animal diagnostics market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin American companion animal diagnostics market into Colombia, Chile, and other countries
    Competitive Landscape Assessment
    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the companion animal diagnostics market
    • Competitive leadership mapping for established players in the US

     

    Get the Full Companion Animal Diagnostic Market Report

    Full forecast, segment splits, and company analysis for all Companion Animal Diagnostic Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status